Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China.

Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China.

<h4>Background</h4>Retrospective evidence indicated potential survival benefit of consolidative stereotactic radiotherapy (SRT) in patients with metastatic driver mutation-negative non-small cell lung cancer (NSCLC) harboring oligo-residual disease (ORD) after effective immune checkpoint...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongru Chen, Lu Yu, Fei Liang, Yue Zhou, Li Chu, Xiao Chu, Xi Yang, Junhua Zhang, Yechun Pang, Zezhou Wang, Zhiyong Yuan, Jianjiao Ni, Zhengfei Zhu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-08-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004680
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pmed.1004680

Similar Items